Balaji, M S, and M Girish. “A Study of Utility of Delta IgG As a Prognostic Marker in Guillain Barre Syndrome After IV Immunoglobulin Treatment”. International journal of health sciences 6, no. S5 (June 23, 2022): 4274–4287. Accessed November 17, 2024. https://sciencescholar.us/journal/index.php/ijhs/article/view/9555.